
<html>
  <head>
    <link href="https://fonts.googleapis.com/css?family=Lato:400,900,700,700italic,400italic,300italic,300,100italic,100,900italic" rel="stylesheet" type="text/css">
    <link href="https://fonts.googleapis.com/css?family=Dosis:400,500,700,800,600,300,200" rel="stylesheet" type="text/css">
    <link rel="stylesheet" type="text/css" href="..\html-styles.css">
  </head>
  <body><h2 id="31atazanavirfinalpkparametertables">3.1 Atazanavir final PK parameter tables</h2>
<p>The compound parameter values of the final atazanavir PBPK model are illustrated below.</p>
<h1 id="compoundatazanavir">Compound: Atazanavir</h1>
<h2 id="parameters">Parameters</h2>
<table>
<thead>
<tr>
<th>Name</th>
<th>Value</th>
<th>Value Origin</th>
<th>Alternative</th>
<th>Default</th>
</tr>
</thead>
<tbody>
<tr>
<td>Solubility at reference pH</td>
<td>50000 mg/l</td>
<td>Assumption</td>
<td>Assumption</td>
<td>True</td>
</tr>
<tr>
<td>Reference pH</td>
<td>7</td>
<td>Assumption</td>
<td>Assumption</td>
<td>True</td>
</tr>
<tr>
<td>Lipophilicity</td>
<td>2.12 Log Units</td>
<td>Publication-Hyland 2008, PMID: 18647303</td>
<td>Measurement</td>
<td>True</td>
</tr>
<tr>
<td>Fraction unbound (plasma, reference value)</td>
<td>0.14</td>
<td>Publication-Rajoli 2015, PMID: 25523214</td>
<td>Measurement</td>
<td>True</td>
</tr>
<tr>
<td>Specific intestinal permeability (transcellular)</td>
<td>9.8649602504E-06 cm/min</td>
<td>Parameter Identification</td>
<td>Optimized</td>
<td>True</td>
</tr>
<tr>
<td>Is small molecule</td>
<td>Yes</td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>Molecular weight</td>
<td>704.8555 g/mol</td>
<td>Internet-drugbank.ca</td>
<td></td>
<td></td>
</tr>
<tr>
<td>Plasma protein binding partner</td>
<td>Unknown</td>
<td></td>
<td></td>
<td></td>
</tr>
</tbody>
</table>
<h2 id="calculationmethods">Calculation methods</h2>
<table>
<thead>
<tr>
<th>Name</th>
<th>Value</th>
</tr>
</thead>
<tbody>
<tr>
<td>Partition coefficients</td>
<td>Rodgers and Rowland</td>
</tr>
<tr>
<td>Cellular permeabilities</td>
<td>PK-Sim Standard</td>
</tr>
</tbody>
</table>
<h2 id="processes">Processes</h2>
<h3 id="metabolizingenzymecyp3a4optimized">Metabolizing Enzyme: CYP3A4-Optimized</h3>
<p>Molecule: CYP3A4</p>
<h4 id="parameters-1">Parameters</h4>
<table>
<thead>
<tr>
<th>Name</th>
<th>Value</th>
<th>Value Origin</th>
</tr>
</thead>
<tbody>
<tr>
<td>Enzyme concentration</td>
<td>1 µmol/l</td>
<td></td>
</tr>
<tr>
<td>Specific clearance</td>
<td>0 1/min</td>
<td></td>
</tr>
<tr>
<td>CLspec/[Enzyme]</td>
<td>1.0383524966 l/µmol/min</td>
<td>Parameter Identification</td>
</tr>
</tbody>
</table>
<h3 id="systemicprocessglomerularfiltrationclinicalpharmacologyreview">Systemic Process: Glomerular Filtration-Clinical Pharmacology Review</h3>
<p>Species: Human</p>
<h4 id="parameters-2">Parameters</h4>
<table>
<thead>
<tr>
<th>Name</th>
<th style="text-align:right;">Value</th>
<th>Value Origin</th>
</tr>
</thead>
<tbody>
<tr>
<td>GFR fraction</td>
<td style="text-align:right;">2.014495446</td>
<td>Parameter Identification</td>
</tr>
</tbody>
</table>
<h3 id="inhibitioncyp3a4perloff2005">Inhibition: CYP3A4-Perloff2005</h3>
<p>Molecule: CYP3A4</p>
<h4 id="parameters-3">Parameters</h4>
<table>
<thead>
<tr>
<th>Name</th>
<th>Value</th>
<th>Value Origin</th>
</tr>
</thead>
<tbody>
<tr>
<td>kinact</td>
<td>0.0033009852632 1/min</td>
<td>Parameter Identification</td>
</tr>
<tr>
<td>K<em>kinact</em>half</td>
<td>0.1292581489 µmol/l</td>
<td>Parameter Identification</td>
</tr>
</tbody>
</table>
<h3 id="inhibitionugt1a1internaldata">Inhibition: UGT1A1-InternalData</h3>
<p>Molecule: UGT1A1</p>
<h4 id="parameters-4">Parameters</h4>
<table>
<thead>
<tr>
<th>Name</th>
<th>Value</th>
<th>Value Origin</th>
</tr>
</thead>
<tbody>
<tr>
<td>Ki_c</td>
<td>0.1672 µmol/l</td>
<td>In Vitro-Calculated from reported Ki and fu,mic</td>
</tr>
<tr>
<td>Ki_u</td>
<td>0.7524 µmol/l</td>
<td>In Vitro-Calculated from reported Ki, fu,mic and alpha</td>
</tr>
</tbody>
</table>
  </body>
</html>
